The primary outcome of interest was the extent of olfaction recovery following COVID-19 infection, using objective or subjective measures. Therefore, a baseline measurement of olfactory loss at time of infection or at study intake was compared to subsequent measurements at follow up intervals. Olfactory loss could be reported as a continuous or categorical measurement (anosmia, hyposmia, normosmia). Our secondary outcomes of interest included time to olfactory recovery, patient prognostic factors (for occurrence and resolution of olfactory dysfunction), and interventional therapies used for olfactory recovery.
Inclusion was limited to studies published in either the English, French, or Spanish languages.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.